Cargando…
New Targeted Treatments for Fragile X Syndrome
Fragile X Syndrome (FXS) is the most common cause of inherited intellectual disability with prevalence rates estimated to be 1:5,000 in males and 1:8,000 in females. The increase of >200 Cytosine Guanine Guanine (CGG) repeats in the 5’ untranslated region of the Fragile X Mental Retardation 1 (FM...
Autores principales: | Protic, Dragana, Salcedo-Arellano, Maria J., Dy, Jeanne Barbara, Potter, Laura A., Hagerman, Randi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930353/ https://www.ncbi.nlm.nih.gov/pubmed/31241016 http://dx.doi.org/10.2174/1573396315666190625110748 |
Ejemplares similares
-
Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018) -
Fragile X Syndrome: From Molecular Aspect to Clinical Treatment
por: Protic, Dragana D., et al.
Publicado: (2022) -
Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017) -
Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022) -
Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and
Colombia: A Model for Other Developing Countries?
por: Protic, Dragana, et al.
Publicado: (2021)